Rhythm Pharmaceuticals, Inc.
A biopharmaceutical company that makes medicines for rare genetic diseases of severe obesity, marked by insatiable hunger and excess weight gain. Its marketed drug, IMCIVREE (setmelanotide), is a precision medicine that restores a signaling pathway in the brain controlling hunger and fullness for patients with conditions such as Bardet-Biedl syndrome and POMC deficiency. Founded in 2008 in Boston, the company's name echoes the body's internal rhythm of hunger and metabolism its medicines aim to reset.
Bought 478.5K · Sold 2.17M
Sold 520.4K
Bought 100.0K
Bought 550.0K
Bought 550.0K
Bought 550.0K
Bought 550.0K
Bought 550.0K
Bought 550.0K
Bought 550.0K
Bought 355.0K
Sold 151.2K
Bought 885.0K
Bought 20.0K
Bought 550.0K
Bought 40.0K
Bought 355.0K
Granted 53.8K · Sold 82.5K
Granted 260.8K · Bought 35.0K · Sold 107.6K
Granted 329.5K · Sold 200.7K
Granted 184.3K · Sold 121.7K
Granted 103.8K · Sold 60.2K
Granted 75.0K · Sold 95.0K
Granted 213.7K · Sold 184.5K
Granted 183.1K · Sold 160.5K
Granted 269.3K · Sold 177.6K
Granted 7.0K
Granted 95.2K · Sold 83.5K
Granted 83.7K · Sold 72.0K
Granted 77.1K · Sold 65.4K
Granted 11.7K
Granted 11.7K
Granted 5.0K · Sold 2.9K
Granted 11.1K · Sold 1.3K
Granted 7.0K
Granted 4.1K · Sold 2.6K
Granted 20.3K · Sold 19.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Foley ToddDirector · 50 transactions | — | 66.69Mas of Mar 2021 | — | 478.5K | 2.17M |
| Kolchinsky Peter +3 co-filersFormer 10% Owner · 12 transactions | — | 9.70Mas of Dec 2020 | — | — | 520.4K |
| Evnin Luke +5 co-filers10% owner · 2 transactions | — | 5.32Mas of Oct 2017 | — | 100.0K | — |
| Barrett M James10% owner · 3 transactions | — | 4.91Mas of Oct 2017 | — | 550.0K | — |
| Barris Peter J10% owner · 3 transactions | — | 4.91Mas of Oct 2017 | — | 550.0K | — |
| Baskett Forest10% owner · 3 transactions | — | 4.91Mas of Oct 2017 | — | 550.0K | — |
| Mott David M10% owner · 3 transactions | — | 4.91Mas of Oct 2017 | — | 550.0K | — |
| NEA Partners 13, Limited Partnership +2 co-filers10% owner · 3 transactions | — | 4.91Mas of Oct 2017 | — | 550.0K | — |
| Sandell Scott D10% owner · 3 transactions | — | 4.91Mas of Oct 2017 | — | 550.0K | — |
| Viswanathan Ravi10% owner · 3 transactions | — | 4.36Mas of Oct 2017 | — | 550.0K | — |
| Isaly Samuel D +2 co-filers10% owner · 2 transactions | — | 2.90Mas of Oct 2017 | — | 355.0K | — |
| Orbimed Advisors LLC +1 co-filerReporting owner · 4 transactions | — | 2.75Mas of May 2018 | — | — | 151.2K |
| Baker Bros. Advisors LP +3 co-filersFormer 10% owner · 4 transactions | — | 2.05Mas of Oct 2017 | — | 885.0K | — |
| Ipsen, S.A.10% owner · 3 transactions | — | 1.65Mas of Oct 2017 | — | 20.0K | — |
| Kerins Patrick J10% owner · 3 transactions | — | 1.43Mas of Oct 2017 | — | 550.0K | — |
| Pfizer Inc10% owner · 3 transactions | — | 1.39Mas of Oct 2017 | — | 40.0K | — |
| Deerfield Management Co +5 co-filersReporting owner · 4 transactions | — | 759.5Kas of Oct 2017 | — | 355.0K | — |
| Gottesdiener Keith MichaelCEO & President, Director · 21 transactions | — | 558.3Kas of Mar 2020 | 53.8K | — | 82.5K |
| Hadley Harbor Master Investors (Cayman) L.P.10% owner · 1 transaction | — | 545.3Kas of Oct 2017 | — | — | — |
| Meeker David PPresident and CEO, Director · 16 transactions | — | 270.5K | 260.8K | 35.0K | 107.6K |
| Smith Hunter CChief Financial Officer · 83 transactions | — | 119.6K | 329.5K | — | 200.7K |
| Levin Mark J +5 co-filers10% owner · 2 transactions | — | 99.1Kas of Sep 2018 | — | — | — |
| Mazabraud YannEVP, Head of International · 24 transactions | — | 66.0K | 184.3K | — | 121.7K |
| Desikan NithyaChief Commercial Officer · 7 transactions | — | 43.6Kas of Aug 2020 | 103.8K | — | 60.2K |
| Van der Ploeg Leonardus H.T.Chief Scientific Officer · 21 transactions | — | 42.3Kas of May 2019 | 75.0K | — | 95.0K |
| Cramer Pamela J.Chief Human Resources Officer · 61 transactions | — | 29.4K | 213.7K | — | 184.5K |
| Lee Jennifer KaydenEVP, Head of North America · 53 transactions | — | 28.5K | 183.1K | — | 160.5K |
| Shulman JosephChief Technical Officer · 64 transactions | — | 25.5K | 269.3K | — | 177.6K |
| Mathers Edward TDirector · 5 transactions | — | 21.2K | 7.0K | — | — |
| Good Jennifer LDirector · 17 transactions | — | 11.7K | 95.2K | — | 83.5K |
| Tetrault LYNN A.Director · 17 transactions | — | 11.7K | 83.7K | — | 72.0K |
| McGirr David W JDirector · 6 transactions | — | 11.7K | 77.1K | — | 65.4K |
| Arbuckle Stuart ADirector · 3 transactions | — | 11.7K | 11.7K | — | — |
| Jean ChristopheDirector · 3 transactions | — | 11.7K | 11.7K | — | — |
| Roberts William T.Chief Accounting Officer · 5 transactions | — | 7.9Kas of Mar 2023 | 5.0K | — | 2.9K |
| Garfield AlastairChief Scientific Officer · 5 transactions | — | 7.8K | 11.1K | — | 1.3K |
| Bedrosian Camille LDirector · 2 transactions | — | 7.0Kas of Jun 2025 | 7.0K | — | — |
| Chien JenniferEVP, Head of North America · 5 transactions | — | 4.9Kas of Feb 2023 | 4.1K | — | 2.6K |
| German Christopher PaulCorporate Controller & CAO · 25 transactions | — | 1.9K | 20.3K | — | 19.0K |
| Exter NeilDirector · 1 transaction | — | 0as of Oct 2017 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +2.39M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.